ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Up 43.5% in March

ENDRA Life Sciences Inc. (NASDAQ:NDRA) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 40,600 shares, a growth of 43.5% from the February 28th total of 28,300 shares. Based on an average trading volume of 19,800 shares, the days-to-cover ratio is currently 2.1 days. Approximately 7.6% of the company’s stock are short sold.

ENDRA Life Sciences Trading Down 0.2 %

Shares of NASDAQ:NDRA traded down $0.01 on Friday, reaching $4.24. The company had a trading volume of 2,336 shares, compared to its average volume of 99,756. The firm has a market capitalization of $2.28 million, a PE ratio of 0.00 and a beta of 0.43. ENDRA Life Sciences has a 52-week low of $3.15 and a 52-week high of $875.00. The firm’s 50 day simple moving average is $4.63 and its 200-day simple moving average is $5.99.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.